Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Leukemia × Blood Specimen Collection × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 15 Neoplasms 12 Colorectal Neoplasms 9 Lung Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Myelodysplastic Syndromes 5 Sarcoma 3 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Squamous Cell 3 Carcinoma, Hepatocellular 3 Brain Neoplasms 3 Uterine Cervical Neoplasms 2 Thrombosis 2 Skin Neoplasms 2 Sezary Syndrome 2 Myeloproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Leukemia, Myeloid, Acute 2 Hodgkin Disease 2 Head and Neck Neoplasms 2 Desmoid Tumors 2 Carcinoma, Renal Cell 2 COVID-19 2 Adenocarcinoma 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1

Interventions

venetoclax 15 Cyclophosphamide 14 fludarabine 7 Cytarabine 7 Azacitidine 7 fludarabine phosphate 6 ruxolitinib 5 Rituximab 5 Decitabine 5 Whole-Body Irradiation 4 Mycophenolic Acid 4 Mesna 4 Melphalan 4 revumenib 3 ibrutinib 3 Vincristine 3 Tacrolimus 3 Peripheral Blood Stem Cell Transplantation 3 Methotrexate 3 Mercaptopurine 3 Interleukin-2 3 Dexamethasone 3 Daunorubicin 3 Dasatinib 3 Busulfan 3 Bone Marrow Transplantation 3 quizartinib 2 ponatinib 2 pembrolizumab 2 pegaspargase 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06649253 2026-01-02

REALL CD9

Rennes University Hospital

Phase NA Recruiting

Other hematologic neoplasm

Leukemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡